Published in Cancer Res on July 01, 2008
Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12. Cell Cycle (2010) 1.63
Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis. Genes Cancer (2010) 1.20
A-kinase anchoring proteins as potential drug targets. Br J Pharmacol (2012) 1.07
Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12. Cancer Metastasis Rev (2012) 0.99
Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling. J Signal Transduct (2012) 0.96
Gravin is a transitory effector of polo-like kinase 1 during cell division. Mol Cell (2012) 0.96
Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies. PLoS One (2012) 0.88
AKAP12 mediates barrier functions of fibrotic scars during CNS repair. PLoS One (2014) 0.85
Prompt meningeal reconstruction mediated by oxygen-sensitive AKAP12 scaffolding protein after central nervous system injury. Nat Commun (2014) 0.84
A mitotic kinase scaffold depleted in testicular seminomas impacts spindle orientation in germ line stem cells. Elife (2015) 0.83
Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12. J Biol Chem (2011) 0.83
Cell shape regulation by Gravin requires N-terminal membrane effector domains. Biochem Biophys Res Commun (2008) 0.82
A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases. Br J Pharmacol (2014) 0.81
Receptor-mediated Ca2+ and PKC signaling triggers the loss of cortical PKA compartmentalization through the redistribution of gravin. Cell Signal (2013) 0.79
Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis. Cancer Res (2008) 0.79
Retinoid-induced expression and activity of an immediate early tumor suppressor gene in vascular smooth muscle cells. PLoS One (2011) 0.78
MicroRNAs as molecular classifiers for cancer. Cell Cycle (2011) 0.78
Carcinogen-induced squamous papillomas and oncogenic progression in the absence of the SSeCKS/AKAP12 metastasis suppressor correlate with FAK upregulation. Int J Cancer (2011) 0.78
A transgenic mouse model for early prostate metastasis to lymph nodes. Cancer Res (2014) 0.78
SSeCKS promotes tumor necrosis factor-alpha autocrine via activating p38 and JNK pathways in Schwann cells. Cell Mol Neurobiol (2010) 0.77
TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation. Oncogene (2016) 0.76
Scaffolding during the cell cycle by A-kinase anchoring proteins. Pflugers Arch (2015) 0.75
HSPA12B: a novel facilitator of lung tumor growth. Oncotarget (2015) 0.75
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell (1995) 12.39
Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell (1996) 8.77
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol (1998) 6.38
Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res (1998) 4.33
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate (2003) 3.44
A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics (1997) 2.65
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A (2001) 2.50
Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res (2005) 2.19
Prevalent mutations in prostate cancer. J Cell Biochem (2006) 2.12
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res (2003) 2.11
Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol (1997) 1.91
The p53-deficient mouse: a model for basic and applied cancer studies. Semin Cancer Biol (1996) 1.86
Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol (2002) 1.83
Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis. Int J Cancer (2007) 1.60
Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem (2004) 1.56
Molecular markers of prostate cancer outcome. Eur J Cancer (2005) 1.52
A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem (1996) 1.45
The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res (2001) 1.27
Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn (2003) 1.23
SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol Cell Biol (2000) 1.21
The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development . Front Biosci (2002) 1.21
Gravin regulates mesodermal cell behavior changes required for axis elongation during zebrafish gastrulation. Genes Dev (2007) 1.17
SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. Cancer Res (2006) 1.16
AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene (2004) 1.14
Src docks to A-kinase anchoring protein gravin, regulating beta2-adrenergic receptor resensitization and recycling. J Biol Chem (2007) 1.13
Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles. J Biol Chem (2004) 1.13
Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res (1996) 1.11
p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. Mol Cell Biol (2006) 1.11
Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. Cancer Res (2005) 1.10
Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Cancer Res (1997) 1.07
Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. J Cell Sci (1999) 1.06
The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma. Urol Oncol (2004) 1.06
A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis. Histochem J (2000) 1.04
SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways. Mol Cancer Res (2006) 1.00
Involvement of PI3K/Akt pathway in prostate cancer--potential strategies for developing targeted therapies. Mini Rev Med Chem (2005) 0.97
AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity. Cancer Lett (2007) 0.93
Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts. Oncogene (2001) 0.93
Of mice without pockets: mouse models to study the function of Rb family proteins. Front Biosci (2007) 0.88
Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis. Mol Carcinog (2006) 0.86
Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res (1996) 0.82
Xgravin-like (Xgl), a novel putative a-kinase anchoring protein (AKAP) expressed during embryonic development in Xenopus. Mech Dev (2001) 0.81
Prostatic intraepithelial neoplasia: a premalignant lesion. J Cell Biochem Suppl (1992) 0.80
Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes (2006) 2.85
SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med (2003) 2.78
Collapsing glomerulopathy. J Am Soc Nephrol (2006) 2.46
Regulatory context is a crucial part of gene function. Trends Genet (2002) 2.37
Ultrasound guidance versus the landmark technique for the placement of central venous catheters in the emergency department. Acad Emerg Med (2002) 2.21
Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12
Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology (2006) 1.98
Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma. Clin Cancer Res (2006) 1.92
Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol (2003) 1.82
HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol (2002) 1.79
Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol (2004) 1.75
Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int (2004) 1.72
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest (2002) 1.70
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12. Cell Cycle (2010) 1.63
Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol (2004) 1.53
Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol (2007) 1.52
Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proc Natl Acad Sci U S A (2006) 1.43
Association of clinical and laboratory variables with ultrasound findings in right upper quadrant abdominal pain. South Med J (2005) 1.42
The kd/kd mouse is a model of collapsing glomerulopathy. J Am Soc Nephrol (2005) 1.37
Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice. J Immunol (2005) 1.34
Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. J Allergy Clin Immunol (2009) 1.34
Translation of the National Institutes of Health Diabetes Prevention Program in African American churches. J Natl Med Assoc (2011) 1.31
Dendritic cells in the kidney. J Am Soc Nephrol (2007) 1.29
Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis. PLoS One (2008) 1.27
The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice. Am J Pathol (2007) 1.27
Computer modeling of promoter organization as a tool to study transcriptional coregulation. FASEB J (2003) 1.26
Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney. J Am Soc Nephrol (2002) 1.23
Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev (2005) 1.22
Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation (2008) 1.22
Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol (2002) 1.21
Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide. PLoS One (2011) 1.20
SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem (2009) 1.19
13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol (2005) 1.17
Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease. Nephron Exp Nephrol (2012) 1.17
Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int (2002) 1.17
FAK-dependent regulation of myofibroblast differentiation. FASEB J (2006) 1.17
SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. Cancer Res (2006) 1.16
Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles. J Biol Chem (2004) 1.13
Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma. Ann Surg (2009) 1.08
Controversies in the pathogenesis of HIV-associated renal diseases. Nat Rev Nephrol (2009) 1.08
Transcript-specific expression profiles derived from sequence-based analysis of standard microarrays. PLoS One (2009) 1.07
Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo. BMC Immunol (2009) 1.06
Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem J (2004) 1.05
Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation (2007) 1.04
v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts. J Biol Chem (2003) 1.04
TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α. Lab Invest (2011) 1.04
Health literacy, health information seeking behaviors and internet use among patients attending a private and public clinic in the same geographic area. J Community Health (2014) 1.03
v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. J Biol Chem (2007) 1.03
CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol (2003) 1.03
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging. J Mol Med (Berl) (2011) 1.02
Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions. J Immunol (2013) 1.01
Origin of parietal podocytes in atubular glomeruli mapped by lineage tracing. J Am Soc Nephrol (2013) 1.00
Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents. J Med Chem (2004) 1.00
Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations. Am J Pathol (2011) 1.00
Collapsing glomerulopathy: an inflammatory podocytopathy? Curr Opin Nephrol Hypertens (2007) 1.00
Genetically engineered stem cells for therapeutic gene delivery. Curr Gene Ther (2007) 0.99
Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion. BMC Cancer (2009) 0.99
CCR10 is expressed in cutaneous T-cell lymphoma. Int J Cancer (2005) 0.98
Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. Kidney Int (2008) 0.98
Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo. J Immunol (2007) 0.98
CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol (2004) 0.97
Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells Dev (2012) 0.97
Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate. Cancer Res (2003) 0.96
It is safe to stop antiretroviral therapy in patients with preantiretroviral CD4 cell counts >250 cells/microL. J Acquir Immune Defic Syndr (2004) 0.96
Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling. J Signal Transduct (2012) 0.96
SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab Invest (2012) 0.95
Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J Am Soc Nephrol (2002) 0.95
Podocyte disorders: Core Curriculum 2011. Am J Kidney Dis (2011) 0.94
Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma. Mod Pathol (2011) 0.94
Gravin orchestrates protein kinase A and β2-adrenergic receptor signaling critical for synaptic plasticity and memory. J Neurosci (2012) 0.94
Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. Biochem Biophys Res Commun (2002) 0.93
Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery. Mol Ther (2011) 0.93
Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy. Stem Cells (2013) 0.93
Calcium signaling in dendritic cells by human or mycobacterial Hsp70 is caused by contamination and is not required for Hsp70-mediated enhancement of cross-presentation. J Biol Chem (2008) 0.92
Current preferences for breast reduction techniques: a survey of board-certified plastic surgeons 2002. Plast Reconstr Surg (2004) 0.92
Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein. Exp Cell Res (2002) 0.91
Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model. Cancer Res (2009) 0.90
A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage. Mol Immunol (2009) 0.89
SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis. BMC Cancer (2006) 0.88
Chemokines bind to sulfatides as revealed by surface plasmon resonance. Biochim Biophys Acta (2005) 0.88
Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am J Pathol (2004) 0.87
JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1. J Immunol (2009) 0.87
Selective binding and presentation of CCL5 by discrete tissue microenvironments during renal inflammation. J Am Soc Nephrol (2007) 0.87
Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions. Anticancer Agents Med Chem (2011) 0.86
Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro. Dig Dis Sci (2008) 0.86
CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases. Drug News Perspect (2006) 0.85
Template-guided versus undirected written medical documentation: a prospective, randomized trial in a family medicine residency clinic. J Am Board Fam Pract (2005) 0.85
GSK3beta plays dirty in acute kidney injury. J Am Soc Nephrol (2010) 0.84
A complex pattern of chemokine receptor expression is seen in osteosarcoma. BMC Cancer (2008) 0.84
SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization. Stem Cells (2013) 0.84
Dendritic cells in human renal inflammation--Part II. Nephron Exp Nephrol (2011) 0.84
Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src. Int J Cancer (2011) 0.84
The basic residue cluster (55)KKWVR(59) in CCL5 is required for in vivo biologic function. Mol Immunol (2009) 0.84
A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy. PLoS One (2013) 0.83
Murine prostate cancer inhibits both in vivo and in vitro generation of dendritic cells from bone marrow precursors. Prostate (2004) 0.83